Masod Mahmod Haji Ahmed a and Dana Ahmed Sharif b

a Kurdistan Board of Medical Specialties Candidate. 

b Department of Medicine, College of Medicine, University of Sulaimani. 

Submitted: 4/3/2018; Accepted: 25/7/2018; Published 15/10/2018

DOI Link: https://doi.org/10.17656/jsmc.10164 



Thalassemia major is one of the most inherited disorders in the Middle East; it has many complications related to iron overload and hepatitis viral transmission; complication of iron overload has destructing effect on many organ systems including liver; heart; pancreas; and lung. In the lung lead to pulmonary arterial hypertension which is defined as pulmonary artery systolic pressure ≥25mmHg during rest.


To detect the prevalence of pulmonary hypertension in patients with thalassemia major and how supportive measures affecting outcome of it.

Patients and Methods

A cross sectional study undertaken in Shaheid Hemn Teaching hospital, center for internal medicine diseases with collaboration of thalassemia center inside the hospital; 100 thalassemia major patients who are diagnosed previously by hemoglobin electrophoresis without any other comorbidity taken as a sample and echocardiography done using Phillips CX50 machine of 2009 model; the data then collected and using SPSS v23 for analyzing data.


Study show 53% of thalassemia major has evidence of increased pulmonary artery pressure and only 1% has clinically significant pressure; splenectomy show high risk factor for occurrence of pulmonary hypertension but other supportive measures has no obstacle effect in its occurrence.


Most thalassemia major patients have evidence of pulmonary hypertension at least mild one; and putting splenectomy as a last line of managing them is recommended.


Thalassemia Major, Splenectomy, Pulmonary Hypertension, Echocardiography.


1. Walker BR, Colledge NR, Ralston S, Penman ID, Britton R, editors. Davidson’s principles and practice of medicine. 22nd edition. Edinburgh ; New York: Churchill Livingstone/Elsevier; 2014. 1372 p. 

2. Vlahos AP, Koutsouka FP, Papamichael ND, Makis A, Baltogiannis GG, Athanasiou E, et al. Determinants of Pulmonary Hypertension in Patients with Beta-Thalassemia Major and Normal Ventricular Function. Acta Haematol. 2012;128(2):124–9. 

3. Cecil RL, Goldman L, Schafer AI, editors. Goldman’s Cecil medicine. 24th ed. Philadelphia: Elsevier/Saunders; 2012. 2569 p. 

4. Du Z-D, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1997 Sep;134(3):532–7. 

5. Derchi G, Fonti A, Forni GL. Pulmonary hypertension in patients with thalassemia major. Am HEART J. 1999;138(2):384. 

6. El-Beshlawy A, Youssry I, El-Saidi S, El Accaoui R, Mansi Y, Makhlouf A, et al. Pulmonary hypertension in β-thalassemia major and the role of l-carnitine therapy. Pediatr Hematol Oncol. 2008 Jan;25(8):734–43. 

7. Meloni A, Detterich J, Pepe A, Harmatz P, Coates TD, Wood JC. Pulmonary hypertension in well-transfused thalassemia major patients. Blood Cells Mol Dis Blood Cells Mol Dis. 2015;54(2):189–94. 

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.